51 related articles for article (PubMed ID: 17021049)
1. Differential utilization of transcription activation subdomains by distinct coactivators regulates Pit-1 basal and Ras responsiveness.
Duval DL; Jonsen MD; Diamond SE; Murapa P; Jean A; Gutierrez-Hartmann A
Mol Endocrinol; 2007 Jan; 21(1):172-85. PubMed ID: 17021049
[TBL] [Abstract][Full Text] [Related]
2. Ras signaling and transcriptional synergy at a flexible Ets-1/Pit-1 composite DNA element is defined by the assembly of selective activation domains.
Duval DL; Jean A; Gutierrez-Hartmann A
J Biol Chem; 2003 Oct; 278(41):39684-96. PubMed ID: 12902343
[TBL] [Abstract][Full Text] [Related]
3. The 26-amino acid beta-motif of the Pit-1beta transcription factor is a dominant and independent repressor domain.
Jonsen MD; Duval DL; Gutierrez-Hartmann A
Mol Endocrinol; 2009 Sep; 23(9):1371-84. PubMed ID: 19556346
[TBL] [Abstract][Full Text] [Related]
4. A 26-amino acid insertion domain defines a functional transcription switch motif in Pit-1beta.
Diamond SE; Gutierrez-Hartmann A
J Biol Chem; 1996 Nov; 271(46):28925-32. PubMed ID: 8910541
[TBL] [Abstract][Full Text] [Related]
5. The Pit-1beta domain dictates active repression and alteration of histone acetylation of the proximal prolactin promoter.
Diamond SE; Gutierrez-Hartmann A
J Biol Chem; 2000 Oct; 275(40):30977-86. PubMed ID: 10921928
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of the protein kinase A response of the rat prolactin promoter: differential effects of distinct Pit-1 isoforms and functional interaction with Oct-1.
Diamond SE; Chiono M; Gutierrez-Hartmann A
Mol Endocrinol; 1999 Feb; 13(2):228-38. PubMed ID: 9973253
[TBL] [Abstract][Full Text] [Related]
7. A Pit-1 threonine 220 phosphomimic reduces binding to monomeric DNA sites to inhibit Ras and estrogen stimulation of the prolactin gene promoter.
Jean A; Gutierrez-Hartmann A; Duval DL
Mol Endocrinol; 2010 Jan; 24(1):91-103. PubMed ID: 19887646
[TBL] [Abstract][Full Text] [Related]
8. Expression of Pit-1 in nonsomatotrope cell lines induces human growth hormone locus control region histone modification and hGH-N transcription.
Hogan KA; Jefferson HS; Karschner VA; Shewchuk BM
J Mol Biol; 2009 Jul; 390(1):26-44. PubMed ID: 19427323
[TBL] [Abstract][Full Text] [Related]
9. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription.
Faiola F; Liu X; Lo S; Pan S; Zhang K; Lymar E; Farina A; Martinez E
Mol Cell Biol; 2005 Dec; 25(23):10220-34. PubMed ID: 16287840
[TBL] [Abstract][Full Text] [Related]
10. Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: functional and structural correlates.
Vallette-Kasic S; Pellegrini-Bouiller I; Sampieri F; Gunz G; Diaz A; Radovick S; Enjalbert A; Brue T
Mol Endocrinol; 2001 Mar; 15(3):411-20. PubMed ID: 11222742
[TBL] [Abstract][Full Text] [Related]
11. Repression of the prolactin promoter: a functional consequence of the heterodimerization between Pit-1 and Pit-1 beta.
Sporici RA; Hodskins JS; Locasto DM; Meszaros LB; Ferry AL; Weidner AM; Rinehart CA; Bailey JC; Mains IM; Diamond SE
J Mol Endocrinol; 2005 Oct; 35(2):317-31. PubMed ID: 16216912
[TBL] [Abstract][Full Text] [Related]
12. An alternative Pit-1 RNA splicing product reveals modular binding and nonmodular transcriptional activities of the POU-specific domain.
Voss JW; Wilson L; Rhodes SJ; Rosenfeld MG
Mol Endocrinol; 1993 Dec; 7(12):1551-60. PubMed ID: 8145762
[TBL] [Abstract][Full Text] [Related]
13. Structure and functional analysis of a tilapia (Oreochromis mossambicus) growth hormone gene: activation and repression by pituitary transcription factor Pit-1.
Sekkali B; Brim H; Muller M; Argenton F; Bortolussi M; Colombo L; Belayew A; Martial JA
DNA Cell Biol; 1999 Jun; 18(6):489-502. PubMed ID: 10390158
[TBL] [Abstract][Full Text] [Related]
14. Pit-1 binding sites mediate transcriptional responses to cyclic adenosine 3',5'-monophosphate through a mechanism that does not require inducible phosphorylation of Pit-1.
Okimura Y; Howard PW; Maurer RA
Mol Endocrinol; 1994 Nov; 8(11):1559-65. PubMed ID: 7877624
[TBL] [Abstract][Full Text] [Related]
15. Inactivating Pit-1 mutations alter subnuclear dynamics suggesting a protein misfolding and nuclear stress response.
Sharp ZD; Stenoien DL; Mancini MG; Ouspenski II; Mancini MA
J Cell Biochem; 2004 Jul; 92(4):664-78. PubMed ID: 15211565
[TBL] [Abstract][Full Text] [Related]
16. c-Myc inhibits Ras-mediated differentiation of pheochromocytoma cells by blocking c-Jun up-regulation.
Vaqué JP; Fernández-García B; García-Sanz P; Ferrandiz N; Bretones G; Calvo F; Crespo P; Marín MC; León J
Mol Cancer Res; 2008 Feb; 6(2):325-39. PubMed ID: 18314492
[TBL] [Abstract][Full Text] [Related]
17. Identification of an N-terminal transcriptional activation domain within Brn3b/POU4f2.
Martin SE; Mu X; Klein WH
Differentiation; 2005 Feb; 73(1):18-27. PubMed ID: 15733064
[TBL] [Abstract][Full Text] [Related]
18. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
Deng T; Karin M
Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
[TBL] [Abstract][Full Text] [Related]
19. Expression cloning and characterization of PREB (prolactin regulatory element binding), a novel WD motif DNA-binding protein with a capacity to regulate prolactin promoter activity.
Fliss MS; Hinkle PM; Bancroft C
Mol Endocrinol; 1999 Apr; 13(4):644-57. PubMed ID: 10194769
[TBL] [Abstract][Full Text] [Related]
20. An inhibitory region of the DNA-binding domain of thyroid hormone receptor blocks hormone-dependent transactivation.
Liu Y; Takeshita A; Nagaya T; Baniahmad A; Chin WW; Yen PM
Mol Endocrinol; 1998 Jan; 12(1):34-44. PubMed ID: 9440808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
